"Executing differently takes courage" (3/5) - Trusting the ground : navigating volatility, growth and partnerships across the EEMEA zone
Épisode de Pharma Minds par Nathalie Lahitte · 3 août 2026 · 23 min
What do we do when the ground is unstable and information is incomplete? We are told to wait for the right conditions. But what if waiting costs more than acting? The real risk is failing to achieve your purpose.
Welcome to Pharma Minds, Summer Series "Executing differently takes courage". I chose this specific conversation because Marc is the one who speaks best about what execution requires when the context refuses to stabilize. Through his experience, I wanted to explore what it concretely costs to actually do what you said you would do. His answer is very simple: we trust the ground and move forward. It reveals that accepting certain departures, stopping certain projects, and changing directions are the necessary costs of executing with integrity.
Marc Gailhardou (who has since been appointed President Intercontinental Region at MSD) brings this perspective from his role leading the EEMEA zone for MSD, while also serving on the board of the digital health startup The Resilience in Oncology. Tasked with managing a geographical area consisting of 25 percent of the world's population, his impossible context is one of permanent volatility. From maintaining operations across war zones to meeting the demands of emerging economies, he proves that long-term vision requires immediate, bold action.
In this episode, we cover:
◾️Leading Through Volatility : Managing safety, compliance, and operations across the diverse EEMEA region.
◾️The Appetite for the Future : Why high-growth markets embrace bold strategies while mature markets hesitate.
◾️Career as a Marathon : Moving out of your comfort zone, creating options, and knowing when it is time to transition.
◾️Corporate to Startup : Gaining agility, speed, and new perspectives through board roles at organizations like The Resilience in Oncology.
◾️Clarity Over Brutality : Focusing on the task rather than attacking the person to lead with respect.
Execution without stability is rarely comfortable. It demands hard choices and decisive momentum. Clarity wins over caution every time.
👉 How do you balance the need to act with the pressure to wait for better data? Let us know in the comments.
Science creates hope. Reality decides impact.
If you want to follow the whole series, don't forget to subscribe.
-
This episode has been translated with the help of AI tools and edited to align with the editorial direction of this series.
Originally released on: 15/12/2025.
To listen to the original French version of this episode: https://smartlink.ausha.co/pharma-minds/48-why-avoiding-risk-is-the-biggest-threat-to-your-pharma-career.
Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.
Autres épisodes de « Pharma Minds »
- #53 - Libérer du temps soignant : le pari d'un ingénieur à la Clinique Pasteur 19 octobre 2026
- [EXTRAIT] « On a toujours fait comme ça » : comment faire accepter le changement ? avec Loïc Lagarde 18 octobre 2026
- "Europe's Access Dilemma" (BONUS) - The Innovation Wave? Europe’s Payers Aren’t Convinced 12 octobre 2026
- "Europe's Access Dilemma" (5/5) - "Germany has a target on its back" What will Europe give up? 5 octobre 2026
- "Europe's Access Dilemma" (4/5) - Pharma Innovation: Your 8-Year Competitive Window Is Now Just 3 28 septembre 2026
- "Europe's Access Dilemma" (3/5) - MFN Is Already Changing Pharma Launch Strategy. Here’s How to Prepare. 21 septembre 2026
- "Europe's Access Dilemma" (2/5) - Europe Can't Pay More For Innovation: The Case For Co-developing With Asia 14 septembre 2026
- "Europe's Access Dilemma" (1/5) - Europe Is Losing Access to New Medicines. Here’s Why. 7 septembre 2026
- [Insights] Produits frontières : transformer la réglementation en avantage stratégique 2 septembre 2026
- "Executing differently takes courage" (5/5) - From managing global subsidiaries to walking the talk : when execution becomes personal 17 août 2026
- "Executing differently takes courage" (4/5) - Biotech survival and resource allocation : why execution is about choosing what not to do 10 août 2026
- "Executing differently takes courage" (2/5) - The Chinese pharma ecosystem : balancing systemic scale and constant reinvention 27 juillet 2026
- "Executing differently takes courage" (1/5) Transforming Vidal : how a 20-year vision turned a paper book into digital infrastructure 20 juillet 2026
- [Insights] Groupements de pharmacies : ce qu’il faut retenir du rapport IGF-IGAS, avec Hugues Villey Desmeserets 8 juillet 2026
- #52 - Prévention santé : le courage d'investir sans en récolter les fruits soi-même, avec Anne Beinier 22 juin 2026
À propos du podcast
Bienvenue dans Pharma minds, le podcast qui vous emmène dans une aventure captivante à travers la Pharma et la Santé d'aujourd'hui ! Je suis votre hôte, Nathalie Lahitte. Mon objectif ? Découvrir comment des personnalités influentes ont contribué à façonner ce secteur. À chaque épisode, nous…
Épisodes similaires
- Radio et DAB+ : y aura-t-il un jour de la vidéo FM ? – Ça marque ! Le podcast qui décrypte les stratégies de communication digitale et les innovations du marketing éditorial
- Webinaire / découvrir les ETF avec Amundi : comprendre, choisir et investir – Webinaire
- Arrêt maladie, Indemnités limitées à un an : ces enjeux RH que les DRH doivent poser sur la table du CoDir dès maintenant – Capital Humain – Travail, ressources humaines et santé mentale
- [AZIMUT ENTREPRENDRE | 1/3] - 15 000 abonnés sans montrer son visage - Safia Hadidi – Donne le Rythme
- Bénédicte Henry, sa foi, <br>ses convictions et engagements – Les rencontres du père Jacques Thierry
- 1000 ads en une semaine : comment Flytex scale ses ads Meta avec l'IA – Le Rendez-vous E-commerce
Tous les épisodes de Pharma Minds · Plus de podcasts Business